335 related articles for article (PubMed ID: 16374685)
21. Effect of hypertension at presentation on prognosis in patients with dilated cardiomyopathy presenting with normal renal angiogram.
Balije S; Kumar A; Bhawani G; Murthy KS; Kumari N
Indian J Med Res; 2016 Aug; 144(2):281-287. PubMed ID: 27934810
[TBL] [Abstract][Full Text] [Related]
22. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
[TBL] [Abstract][Full Text] [Related]
23. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
Langsjoen PH; Vadhanavikit S; Folkers K
Drugs Exp Clin Res; 1985; 11(8):577-9. PubMed ID: 3836875
[TBL] [Abstract][Full Text] [Related]
24. The role of coenzyme Q10 in heart failure.
Weant KA; Smith KM
Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
[TBL] [Abstract][Full Text] [Related]
25. Radiographic measurements of cardiac size as predictors of outcome in patients with dilated cardiomyopathy.
Ernst ER; Shub C; Bailey KR; Brown LR; Redfield MM
J Card Fail; 2001 Mar; 7(1):13-20. PubMed ID: 11264545
[TBL] [Abstract][Full Text] [Related]
26. The prognostic impact of dynamic ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy and narrow QRS.
D'Andrea A; Mele D; Nistri S; Riegler L; Galderisi M; Agricola E; Losi MA; Ballo P; Mondillo S; Badano LP;
Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):183-9. PubMed ID: 22872513
[TBL] [Abstract][Full Text] [Related]
27. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
Berman M; Erman A; Ben-Gal T; Dvir D; Georghiou GP; Stamler A; Vered Y; Vidne BA; Aravot D
Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947
[TBL] [Abstract][Full Text] [Related]
28. [The chronic effect of coenzyme Q10 in dilated cardiomyopathy: echocardiographic assessment].
Nakanishi M; Yokota Y; Fukuzaki H
Kokyu To Junkan; 1988 Jun; 36(6):655-60. PubMed ID: 3217604
[No Abstract] [Full Text] [Related]
29. Outcomes of plasma exchange for severe dilated cardiomyopathy in children.
Koizumi K; Hoshiai M; Toda T; Katsumata N; Kise H; Hasebe Y; Kouno Y; Kaga S; Suzuki S; Sugita K
Heart Vessels; 2017 Jan; 32(1):61-67. PubMed ID: 27120173
[TBL] [Abstract][Full Text] [Related]
30. Classic-pattern dyssynchrony and electrical activation delays in pediatric dilated cardiomyopathy.
Forsha D; Slorach C; Chen CK; Stephenson EA; Risum N; Hornik C; Wagner G; Mertens L; Barker P; Kisslo J; Friedberg MK
J Am Soc Echocardiogr; 2014 Sep; 27(9):956-64. PubMed ID: 25063467
[TBL] [Abstract][Full Text] [Related]
31. [Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases].
Sinagra G; Maras P; D'Ambrosio A; Gregori D; Bussani R; Silvestri F; Morgera T; Pinamonti B; Salvi A; Alberti E; Di Lenarda A; Lardieri G; Klugmann S; Camerini F
G Ital Cardiol; 1997 Aug; 27(8):758-74. PubMed ID: 9312504
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy.
Avci A; Alizade E; Fidan S; Yesin M; Guler Y; Kargin R; Esen AM
Scand Cardiovasc J; 2014 Aug; 48(4):202-8. PubMed ID: 24912526
[TBL] [Abstract][Full Text] [Related]
33. [Lack of effectiveness of coenzyme Q10 (ubiquinone) in long-term treatment of dilated cardiomyopathy].
Permanetter B; Rössy W; Weingartner F; Bauer R; Seidl KF; Klein G
Z Kardiol; 1989 Jun; 78(6):360-5. PubMed ID: 2667265
[TBL] [Abstract][Full Text] [Related]
34. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.
Sander S; Coleman CI; Patel AA; Kluger J; White CM
J Card Fail; 2006 Aug; 12(6):464-72. PubMed ID: 16911914
[TBL] [Abstract][Full Text] [Related]
35. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.
Mortensen SA
Biofactors; 2003; 18(1-4):79-89. PubMed ID: 14695923
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and prognostic significance of echocardiographic parameters in dilated cardiomyopathy: a prospective study on 225 patients. The Italian Multicenter Study of Cardiomyopathies Group].
Sachero A; Casazza F; Recalcati F; de Maria R; Preti L; Mattioli R; Ferrari F; Capozzi A; Camerini F
G Ital Cardiol; 1992 Sep; 22(9):1077-90. PubMed ID: 1291425
[TBL] [Abstract][Full Text] [Related]
37. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
[TBL] [Abstract][Full Text] [Related]
38. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10.
Langsjoen PH; Langsjoen PH; Folkers K
Int J Tissue React; 1990; 12(3):169-71. PubMed ID: 2276895
[TBL] [Abstract][Full Text] [Related]
39. The effect of coenzyme Q10 in patients with congestive heart failure.
Khatta M; Alexander BS; Krichten CM; Fisher ML; Freudenberger R; Robinson SW; Gottlieb SS
Ann Intern Med; 2000 Apr; 132(8):636-40. PubMed ID: 10766682
[TBL] [Abstract][Full Text] [Related]
40. Results of partial left ventriculectomy in patients with end-stage idiopathic dilated cardiomyopathy.
Dowling RD; Koenig S; Laureano MA; Cerrito P; Gray LA
J Heart Lung Transplant; 1998 Dec; 17(12):1208-12. PubMed ID: 9883762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
